These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34471048)

  • 1. Crystal Structures of the Human Peroxisome Proliferator-Activated Receptor (PPAR)α Ligand-Binding Domain in Complexes with a Series of Phenylpropanoic Acid Derivatives Generated by a Ligand-Exchange Soaking Method.
    Oyama T; Kamata S; Ishii I; Miyachi H
    Biol Pharm Bull; 2021; 44(9):1202-1209. PubMed ID: 34471048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Basis for Anti-non-alcoholic Fatty Liver Disease and Diabetic Dyslipidemia Drug Saroglitazar as a PPAR α/γ Dual Agonist.
    Honda A; Kamata S; Satta C; Machida Y; Uchii K; Terasawa K; Nemoto A; Oyama T; Ishii I
    Biol Pharm Bull; 2021; 44(9):1210-1219. PubMed ID: 34471049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PPARα-Ligand Binding Modes Revealed by X-ray Crystallography].
    Kamata S; Ishii I
    Yakugaku Zasshi; 2021; 141(11):1267-1274. PubMed ID: 34719550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptability and selectivity of human peroxisome proliferator-activated receptor (PPAR) pan agonists revealed from crystal structures.
    Oyama T; Toyota K; Waku T; Hirakawa Y; Nagasawa N; Kasuga JI; Hashimoto Y; Miyachi H; Morikawa K
    Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):786-95. PubMed ID: 19622862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of co-crystals of human PPAR
    Kamata S; Oyama T; Ishii I
    STAR Protoc; 2021 Mar; 2(1):100364. PubMed ID: 33718889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures of the ligand-binding domain of human peroxisome proliferator-activated receptor δ in complexes with phenylpropanoic acid derivatives and a pyridine carboxylic acid derivative.
    Oyama T; Takiguchi K; Miyachi H
    Acta Crystallogr F Struct Biol Commun; 2022 Feb; 78(Pt 2):81-87. PubMed ID: 35102897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptors (PPARs) have multiple binding points that accommodate ligands in various conformations: phenylpropanoic acid-type PPAR ligands bind to PPAR in different conformations, depending on the subtype.
    Kuwabara N; Oyama T; Tomioka D; Ohashi M; Yanagisawa J; Shimizu T; Miyachi H
    J Med Chem; 2012 Jan; 55(2):893-902. PubMed ID: 22185225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional fluorescence properties of pyrene-based peroxisome proliferator-activated receptor (PPAR) α/δ dual agonist.
    Ban S; Oyama T; Kasuga J; Ohgane K; Nishio Y; Morikawa K; Hashimoto Y; Miyachi H
    Bioorg Med Chem; 2012 Jun; 20(11):3460-4. PubMed ID: 22551628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and Structural Insights into Human PPARα/δ/γ Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate.
    Honda A; Kamata S; Akahane M; Machida Y; Uchii K; Shiiyama Y; Habu Y; Miyawaki S; Kaneko C; Oyama T; Ishii I
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?
    Gani OA
    Cardiovasc Diabetol; 2008 Mar; 7():6. PubMed ID: 18355413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family.
    Cronet P; Petersen JF; Folmer R; Blomberg N; Sjöblom K; Karlsson U; Lindstedt EL; Bamberg K
    Structure; 2001 Aug; 9(8):699-706. PubMed ID: 11587644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of fatty acyl-coenzyme A thioester ligands of hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha.
    Schroeder F; Huang H; Hostetler HA; Petrescu AD; Hertz R; Bar-Tana J; Kier AB
    Lipids; 2005 Jun; 40(6):559-68. PubMed ID: 16149734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism of peroxisome proliferator-activated receptor α activation by WY14643: a new mode of ligand recognition and receptor stabilization.
    Bernardes A; Souza PC; Muniz JR; Ricci CG; Ayers SD; Parekh NM; Godoy AS; Trivella DB; Reinach P; Webb P; Skaf MS; Polikarpov I
    J Mol Biol; 2013 Aug; 425(16):2878-93. PubMed ID: 23707408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Basis for PPARα Activation by 1H-pyrazolo-[3,4-b]pyridine Derivatives.
    Yoshida T; Oki H; Doi M; Fukuda S; Yuzuriha T; Tabata R; Ishimoto K; Kawahara K; Ohkubo T; Miyachi H; Doi T; Tachibana K
    Sci Rep; 2020 May; 10(1):7623. PubMed ID: 32376995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the peroxisome proliferator-activated receptor gamma (PPARgamma) ligand binding domain complexed with a novel partial agonist: a new region of the hydrophobic pocket could be exploited for drug design.
    Montanari R; Saccoccia F; Scotti E; Crestani M; Godio C; Gilardi F; Loiodice F; Fracchiolla G; Laghezza A; Tortorella P; Lavecchia A; Novellino E; Mazza F; Aschi M; Pochetti G
    J Med Chem; 2008 Dec; 51(24):7768-76. PubMed ID: 19053776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of peroxisome proliferator-activated receptor α (PPARα) activators with a ligand-screening system using a human PPARα-expressing cell line.
    Tachibana K; Yuzuriha T; Tabata R; Fukuda S; Maegawa T; Takahashi R; Tanimoto K; Tsujino H; Nunomura K; Lin B; Matsuura Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Kobayashi T; Ishimoto K; Miyachi H; Doi T
    J Biol Chem; 2018 Jun; 293(26):10333-10343. PubMed ID: 29764933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of an enzyme-linked immunosorbent assay to screen ligand of Peroxisome proliferator-activated receptor alpha.
    Cho MC; Lee S; Choi HS; Yang Y; Tae Hong J; Kim SJ; Yoon DY
    Immunopharmacol Immunotoxicol; 2009; 31(3):459-67. PubMed ID: 19263263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Binding Regions of Bilirubin in the Ligand-Binding Pocket of the Peroxisome Proliferator-Activated Receptor-A (PPARalpha).
    Gordon DM; Hong SH; Kipp ZA; Hinds TD
    Molecules; 2021 May; 26(10):. PubMed ID: 34067839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LT175 is a novel PPARα/γ ligand with potent insulin-sensitizing effects and reduced adipogenic properties.
    Gilardi F; Giudici M; Mitro N; Maschi O; Guerrini U; Rando G; Maggi A; Cermenati G; Laghezza A; Loiodice F; Pochetti G; Lavecchia A; Caruso D; De Fabiani E; Bamberg K; Crestani M
    J Biol Chem; 2014 Mar; 289(10):6908-6920. PubMed ID: 24451380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor alpha interacts with high affinity and is conformationally responsive to endogenous ligands.
    Hostetler HA; Petrescu AD; Kier AB; Schroeder F
    J Biol Chem; 2005 May; 280(19):18667-82. PubMed ID: 15774422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.